Name : Mrs. KANTA Patient UID.
: 7754640
Age/Gender : 60 Yrs/Female Visit No. : 15802505090001
Referred Client : LDPL1449-APNEE PATH LAB PVT. LTD. Collected on : 09-May-2025 10:00AM
Referred By : APNI PATH LAB Received on : 09-May-2025 04:14PM
Doctor Name : Dr. SABKA HOSPITAL Reported on : 09-May-2025 04:42PM
Sample Type : Whole Blood EDTA - 17385391,Sod.Fluoride - F - 17385392,Sod.Fluoride - PP - 17385393
HAEMATOLOGY
Test Name Results Unit Bio. Ref. Interval
HBA1C -GLYCOSYLATED HEMOGLOBIN
Hb A1C, GLYCOSYLATED Hb,wb edta 8.70 % Normal <5.7%
Methodology: by HPLC Prediabetes 5.7% to 6.4%
Diabetes 6.5% or higher
Estimated Average Glucose 202.99 mg/dL 68-125
INTERPRETATION
AS PER AMERICAN DIABETES ASSOCIATION (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years < 5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
CLINICAL NOTES
In vitro quantitative determination of HbA1c in whole blood is utilized in long term monitoring of glycemia.The HbA1c level correlates with the mean glucose concentration
prevailing in the course of the patient's recent history (approx - 6-8 weeks) and therefore provides much more reliable information for glycemia monitoring than do determinations
of blood glucose or urinary glucose. It is recommended that the determination of HbA1c be performed at intervals of 4-6 weeks during Diabetes Mellitus therapy. Results of HbA1c
should be assessed in conjunction with the patient's medical history, clinical examinations and other findings.
Some of the factors that influence HbA1c and its measurement [Adapted from Gallagher et al ]
1. Erythropoiesis
- Increased HbA1c: iron, vitamin B12 deficiency, decreased erythropoiesis.
- Decreased HbA1c: administration of erythropoietin, iron, vitamin B12, reticulocytosis, chronic liver disease.
2. Altered Haemoglobin-Genetic or chemical alterations in hemoglobin: hemoglobinopathies, HbF, methemoglobin, may increase or decrease HbA1c.
3. Glycation
- Increased HbA1c: alcoholism, chronic renal failure, decreased intraerythrocytic pH.
- Decreased HbA1c: certain hemoglobinopathies, increased intra-erythrocyte pH.
4. Erythrocyte destruction
- Increased HbA1c: increased erythrocyte life span: Splenectomy.
- Decreased A1c: decreased RBC life span: hemoglobinopathies, splenomegaly, rheumatoid arthritis or drugs such as antiretrovirals, ribavirin & dapsone.
5. Others
- Increased HbA1c: hyperbilirubinemia, carbamylated hemoglobin, alcoholism, large doses of aspirin, chronic opiate use,chronic renal failure
- Decreased HbA1c: hypertriglyceridemia,reticulocytosis, chronic liver disease, aspirin, vitamin C and E,splenomegaly, rheumatoid arthritis or drugs
Note:
1.Shortened RBC life span –HbA1c test will not be accurate when a person has a condition that affects the average lifespan of red blood cells (RBCs), such as hemolytic anemia
or blood loss. When the lifespan of RBCs in circulation is shortened, the A1c result is falsely low and is an unreliable measurement of a person's average glucose over time.
2.Abnormal forms of hemoglobin – The presence of some hemoglobin variants, such as hemoglobin S in sickle cell anemia, may affect certain methods for measuring A1c. In
these cases, fructosamine can be used to monitor glucose control.
estimated Average Glucose (eAG) : based on value calculated according to National Glycohemoglobin Standardization Program (NGSP) criteria.
*** End Of Report ***
Page 1 of 3
Name : Mrs. KANTA Patient UID. : 7754640
Age/Gender : 60 Yrs/Female Visit No. : 15802505090001
Referred Client : LDPL1449-APNEE PATH LAB PVT. LTD. Collected on : 09-May-2025 10:00AM
Referred By : APNI PATH LAB Received on : 09-May-2025 04:14PM
Doctor Name : Dr. SABKA HOSPITAL Reported on : 09-May-2025 05:35PM
Sample Type : Whole Blood EDTA - 17385391,Sod.Fluoride - F - 17385392,Sod.Fluoride - PP - 17385393
BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
BLOOD GLUCOSE FASTING
BLOOD GLUCOSE FASTING,Plasma Sod.F 179.90 mg/dl 59-100
Methodology: Hexokinase
CLINICAL NOTES
Elevated glucose levels (hyperglycemia) are most often encountered clinically in the setting of diabetes mellitus, but they may also occur with pancreatic neoplasms,
hyperthyroidism, and adrenocortical dysfunction. Decreased glucose levels (hypoglycemia) may result from endogenous or exogenous insulin excess, prolonged starvation,
or liver disease.
Fasting Glucose 2 HOURS PP Glucose Diagnosis
<100 <140 Normal
100 to 125 140 to 199 Pre Diabetes
>126 >200 Diabetes
Impaired glucose tolerance (IGT) fasting, means a person has an increased risk of developing type 2 diabetes but does not have it yet. A level of 126 mg/dL or above,
confirmed by repeating the test on another day, means a person has diabetes. IGT (2 hrs Post meal), means a person has an increased risk of developing type 2 diabetes
but does not have it yet. A 2-hour glucose level of 200 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes
Note: Blood glucose level is maintained by a very complex integrated mechanism involving a critical interplay of the release of hormones and action of enzymes on key
metabolic pathways. If postprandial glucose is lower than fasting glucose, it is termed as postprandial reactive hypoglycemia (PRH). The possible cause of PRH are high
insulin sensitivity, exaggerated response of insulin and glucagon-like peptide 1, defects in counter-regulation, very lean individuals, anxious individuals, after massive weight
reduction, women with lower body overweight physical activity prior test, hypoglycemic medication, deliberately eating less or eat a non-carbohydrate meal before testing.
Ref : American Diabetes association standards of medical care.
*** End Of Report ***
Page 2 of 3
Name : Mrs. KANTA Patient UID. : 7754640
Age/Gender : 60 Yrs/Female Visit No. : 15802505090001
Referred Client : LDPL1449-APNEE PATH LAB PVT. LTD. Collected on : 09-May-2025 10:00AM
Referred By : APNI PATH LAB Received on : 09-May-2025 04:14PM
Doctor Name : Dr. SABKA HOSPITAL Reported on : 09-May-2025 05:35PM
Sample Type : Whole Blood EDTA - 17385391,Sod.Fluoride - F - 17385392,Sod.Fluoride - PP - 17385393
BIOCHEMISTRY
Test Name Results Unit Bio. Ref. Interval
BLOOD GLUCOSE PP
BLOOD GLUCOSE PP,Plasma Sod.F 272.00 mg/dL 80 - 140
Methodology: Hexokinase
Interpretation
Elevated glucose levels (hyperglycemia) are most often encountered clinically in the setting of diabetes mellitus, but they may also occur with pancreatic neoplasms,
hyperthyroidism, and adrenocortical dysfunction. Decreased glucose levels (hypoglycemia) may result from endogenous or exogenous insulin excess, prolonged starvation,
or liver disease.
Fasting Glucose 2 HOURS PP Glucose Diagnosis
<100 <140 Normal
100 to 125 140 to 199 Pre Diabetes
>126 >200 Diabetes
Impaired glucose tolerance (IGT) fasting, means a person has an increased risk of developing type 2 diabetes but does not have it yet. A level of 126 mg/dL or above,
confirmed by repeating the test on another day, means a person has diabetes. IGT (2 hrs Post meal), means a person has an increased risk of developing type 2 diabetes
but does not have it yet. A 2-hour glucose level of 200 mg/dL or above, confirmed by repeating the test on another day, means a person has diabetes
Ref : American Diabetes association standards of medical care.
*** End Of Report ***
Page 3 of 3
